Markets › United States › NAS › ENGN

enGene Therapeutics Inc

NAS:ENGNHealthcarenasdaq_composite

$1.70+7.28%LiveIn session · ≈ AED 6.22 · Market cap $113.59M · Next earnings Wed 23 Dec

Ratio	FY2021	FY2022	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−0.2%	−19.2%	0.0%	−137.8%	−20.2%	−69.9%	−69.9%	+0.0 pts
Return on assets	−0.2%	−18.5%	0.0%	−114.9%	−17.7%	−53.0%	−53.0%	+0.0 pts
Return on capital employed	−0.2%	−14.8%	−1.4%	−31.9%	−21.0%	−65.0%	—	—
Debt / equity	0.0×	0.3×	0.0×	0.1×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	0.0%	24.3%	0.0%	11.2%	8.0%	14.4%	—	—
Interest coverage	0.0×	−13.7×	0.0×	−5.3×	−22.3×	−41.1×	—	—
Current ratio	4.8×	0.6×	0.6×	16.3×	16.9×	6.3×	6.3×	+0.0%
Quick ratio	4.8×	0.6×	0.6×	16.3×	16.9×	6.3×	—	—
Cash ratio	3.3×	0.4×	0.4×	15.5×	11.8×	1.6×	1.6×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	—	—	—	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—